1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Improving diagnosis TB laboratory strengthening.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
Vaccine in National Immunization Programme Update March 2015.
World Health Organization
What, Where, How and Action Steps… XDR-TB
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
The Global Plan to Stop TB, (1)
World Health Organization
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
CARICOM THE MILLENIUM DEVELOPMENT GOALS (MDG). CARICOM BACKGROUNDBACKGROUND ► GOALS AND TARGETS WHICH ARE: TIME- BOUND AND MEASUREABLE BOUND AND MEASUREABLE.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.
WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
Country Office for Bangladesh Towards reaching the Millennium Development Goals Dr Erwin Cooreman Medical Officer (TB) WHO-Bangladesh.
The 8 Millenium Development Goals. ERADICATE EXTREME POVERTY AND HUNGER Target 1A: Halve, between 1990 and 2015, the proportion of people living on less.
Current Health Concerns: Tuberculosis Saharwash Jamali Hamna Jaffar.
MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
SAGE 2010 Sampling Distribution
Palliative Care and M/XDR-TB Global burden of M/XDR-TB
financial requirements
reporting rate of discarded cases* per 100'000 population**
TUBERCULOSIS, TB/HIV & MDR-TB
اپيدميولوژي و كنترل سِل
PROGRESS IN GLOBAL TB CONTROL
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
Key issues in DOTS implementation
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Sampling Distribution
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
Countries having introduced HepB vaccine
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
PROGRESS IN GLOBAL TB CONTROL
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
The STOP TB Strategy – 2009 VISION: A TB-free world
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova

2 What is TB?  One of the oldest disease known  Usually a respiratory disease due to infection by Mycobacterium tuberculosis.  Mode of spread TB Patient  Cough   infect others

3 How big TB problem is? Leading infectious killer in the world  Globally: 2.1 billion infected 9.2 million cases & 1.7 million deaths a year 0.7M cases & 0.2M deaths in HIV+ 500K people a year become infected with MDR-TB  25% of all avoidable deaths in economically productive age groups are due to TB.  Regionally: 180M infected 560,000 cases & 110,000 deaths a year Yet it is completely curable and is (relatively) inexpensive to cure.

4 Estimated TB incidence rate, 2006 Estimated new TB cases (all forms) per population The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved No estimate or more

5 Estimated HIV prevalence in new TB cases, 2006 No estimate 0–4 20–49 50 or more 5–19 HIV prevalence in TB cases, (%) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO All rights reserved

6 > 100 Incidence rate (/ ) < 20 Bahrain Palestine Estimated TB incidence rate in EMR WHO Global TB Report 2007

7 How to fight against TB? Global Plan to Stop TB  Comprehensive plan to achieve 70/85 & MDG ( )  Activities & Cost  USD 56 Billion for world  USD 3.1 Billion for EMR

8 Global Plan to Stop TB: Goals, Targets and Strategies for TB control MILLENIUM DEVELOPMENT GOAL 6 Combat HIV/AIDS, malaria and other diseases Target 8: Have halted by 2015 and begun to reverse the incidence of malaria and other major diseases Indicator 23: The global burden of TB (per capita prevalence and death rates) will be reduced by 50% relative to 1990 levels  Prevalence 50% of ≈ 300/100K  Deaths 50% of ≈ 30/100K (< 1m deaths) Indicator 24: proportion of TB cases detected and cured under DOTS  Case detection 70% (> 6 m diagnosed)  Treatment success 85% (> 5 m cured DOTS) By 2050: The global incidence of active TB will be less than 1 case per million population per year (Stop TB Partnership).

9 DOTS status in 2006: countries close to targets 99 countries reported treatment success rates 70% or over and DOTS detection rates 50% or over 32 countries (including 2 countries out of range of graph) have reached both targets.

10 The components of the Stop TB Strategy ( ) 1.DOTS expansion and enhancement 2.Addressing TB/HIV, MDR-TB and other challenges 3.Contributing to health system strengthening 4.Engaging all care providers 5.Empowering patients, and communities 6.Enabling and promoting research

11 WHO Stop TB Strategy & “DOTS” Care for TB patients & community participation in TB control Diagnosis by laboratory (sputum examination) 6 month treatment with >95% efficacy Strategy to involve private sector & community e.g. cure rate is above 85% in most EMR countries

12 What are the challenges in TB care? 1.Low health priority 2.Limited resources (human and financial) 3.Low case detection and Treatment adherence, Drug resistance  Stigma and discrimination  Poverty  Wars and conflicts  HIV/AIDS and TB  Mobile population and migration